Search Results

You searched for : foodanddrugadministration

	Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment Hoth Therapeutics, Inc. a biopharmaceutical company, today announced that it has signed a production agreement for both GLP and GMP materials associated with HT-001 ... Jan 01
	OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test The OraSure SARS-CoV-2 Antibody ELISA is intended for the qualitative detection of total antibodies to SARS-CoV-2 in human oral fluid specimens ... Dec 22
	APhA Statement Following Emergency Use Authorization of the Moderna COVID-19 Vaccine Statement from Scott J. Knoer, MS, PharmD, FASHP, executive vice president and CEO of the American Pharmacists Association, upon the Food and Drug Administration's (... Dec 19
	Coronavirus (COVID-19) Update: FDA Issues New Authorization for the BinaxNOW COVID-19 Ag Card Home Test Today, the U.S. Food and Drug Administration issued a new emergency use authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test which ... Dec 17
	FDA Approves Y-mAbsâ€™ DANYELZAÂ® (naxitamab-gqgk) for the Treatment of Neuroblastoma Y-mAbs Therapeutics today announced that the U.S. Food and Drug Administration (â€œFDAâ€) has approved DANYELZA (naxitamab-gqgk) for the Treatment of Neuroblastoma.... Nov 26
	FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease. The U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for avalglucosidase alfa for long-term enzyme ... Nov 20
	North America Allergy Immunotherapies Market to Forecast to 2027- COVID-19 Impact and Analysis- By Treatment, Allergy type, Distribution Channel and Geography North America Allergy Immunotherapies Market to Forecast to 2027- COVID-19 Impact and Analysis- By Treatment, Allergy type, Distribution Channel and Geography... Oct 28
	Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Incâ€™s antiviral drug remdesivir for treating patients hospitalized with COVID-19... Oct 23
8 Matching result(s) found!

-Advertisements-

Trending Now
	Olympus Launches New 4K Camera Head for Urological EndoscopySeptember 20, 2024
	Mpox Strikes Again: Is Kerala Prepared for the Next Global Health Crisis?September 20, 2024
	The Surge of Swine Flu, Dengue, and Other Infections: Delhi NCR Faces a Viral StormSeptember 20, 2024
	Finding the cause of Severe Combined Immunodeficiency (SCID) & Omen SyndromeSeptember 20, 2024
	From Doctor to Dark Web: Star Health’s Customer Data Exploited on TelegramSeptember 20, 2024
	Feminism is the bedrock for a socially just and ecologically sustainable worldSeptember 19, 2024
	Leading AI-powered Blue Collar recruitment platform Vahan.ai secures $10 million funding in Series B led by Khosla Ventures; Moves closer to its endeavour of providing employment opportunities to 1 billion people September 19, 2024
	The Hidden Catastrophe: How Malnutrition Could Define Our FutureSeptember 18, 2024
	Redcliffe Labs Raises $42 Million in Series C Funding: A Step Toward Transforming HealthcareSeptember 18, 2024
	Corporate Greed and Young Lives Lost: How Overwork Is Claiming VictimsSeptember 18, 2024
	Tata Soulfull launches Masala Muesli: A game-changer in breakfast cereals, crafted for Indian tasteSeptember 18, 2024
	Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled MannerSeptember 18, 2024
	Sri Sathya Sai Annapoorna Trust’s nutrition programme serves 10 million school-going children becoming World’s largest, set to get bigger September 17, 2024
	What are Multi-Source Edible Oils & Why They’re Good For YouSeptember 17, 2024
	GST Reduction on Cancer Drugs: A Lifeline for Patients Battling CancerSeptember 17, 2024
	Brinton Pharmaceuticals Ltd. launches UV DOUX Lip Lightening Balm in India: Restore Natural Lip Color with SPF 40 ProtectionSeptember 17, 2024
	The Looming Threat of Antibiotic Resistance: A Global Crisis in the MakingSeptember 17, 2024
	India's Bold Stand: Steering the Global Agenda to Crush Doping in SportsSeptember 17, 2024
	Why Your Mammogram Might Be More Than Just a Cancer Screening: Insights on Cardiovascular RiskSeptember 17, 2024
	Why Toppers are Dying: The Dangerous Disconnect Between Success and Well-BeingSeptember 17, 2024

Search Results

Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment

OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test

APhA Statement Following Emergency Use Authorization of the Moderna COVID-19 Vaccine

Coronavirus (COVID-19) Update: FDA Issues New Authorization for the BinaxNOW COVID-19 Ag Card Home Test

FDA Approves Y-mAbsâ€™ DANYELZAÂ® (naxitamab-gqgk) for the Treatment of Neuroblastoma

FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease.

North America Allergy Immunotherapies Market to Forecast to 2027- COVID-19 Impact and Analysis- By Treatment, Allergy type, Distribution Channel and Geography

Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients

Trending Now